About MindWalk Holdings Corp
- Industry: Life Sciences Tools & Services
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.mindwalkai.com/
Frequently Asked Questions
What is the 52-week range for HYFT?
The 52-week high is $2.99 and the 52-week low is $0.99.
What is the P/E ratio for HYFT?
The P/E ratio data is currently unavailable.
What is the dividend yield for HYFT?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -133.33%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -105.20%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 6.74.
Analyst Recommendation Trends
Wall Street analyst consensus for HYFT over the last few months:
Latest HYFT News
AI Drug Discovery Forecasts Vary Widely as Sector Shifts to Deployment
Towards Healthcare projects that the global AI in drug discovery market will grow from $19.89 billion in 2025 to $160.49 billion by 2035, a compound annual growth rate of 23.22%. Active Companies from around the markets with current developments this week include: MindWalk Holdings Corp. (NASDAQ: HYFT), AbCellera Biologics Inc. (NASDAQ: ABCL), Eli Lilly and Company (NYSE: LLY), Twist Bioscience Corporation (NASDAQ: TWST) and Tempus AI, Inc. (NASDAQ: TEM).
MindWalk Appoints Kim Remizowski to Board of Directors as Independent Director
AUSTIN, Texas, October 01, 2026--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today announced the appointment of Kim Remizowski to its Board of Directors as an independent director, effective September 29, 2026. Mr. Remizowski will serve on the Audit Committee and the Compensation, Nomination and Governance Committee. The Board has determined that he qualifies as an independent director under Nasdaq listing rules and as an audit committee financial expert under a
What Is Advanced Micro Devices (AMD) Proving In Edge AI And Life Sciences?
Advanced Micro Devices (NasdaqGS:AMD) and Advantech announced a collaboration to accelerate Edge AI workloads using AMD embedded and GPU platforms. MindWalk has moved OpenFold3 into production on AMD Instinct GPUs, supported by inference microservices for life sciences workflows. The Advantech alliance focuses on scalable, partner-led Edge AI solutions, while MindWalk highlights regulated, production-grade scientific use cases on AMD hardware. The Advantech Edge AI work and MindWalk...
MindWalk (HYFT) Is Pivoting to Recurring AI Revenue. Can ReefIQ Offset Widening Losses?
Commercial launch of ReefIQ data platform marks a strategic pivot for MindWalk Holdings Corp. (NASDAQ:HYFT). In its first quarter FY27 report, the company also highlighted its transition toward platform-based recurring revenues. It posted C$3.8 million in revenue, up 21.3% compared to the same period last year. Gross profit of C$2.2 million represented a 47.1% year-over-year […]
Advanced Micro Devices (AMD) Reaches $1 Trillion Market Value
Advanced Micro Devices (NasdaqGS:AMD) reached an estimated US$1 trillion market capitalization on 21 September 2026, a first for the stock. The valuation milestone comes as AMD expands AI chip deployments into data center computing and regulated AI infrastructure workloads. Recent use cases for AMD hardware include MindWalk’s production-grade OpenFold3, AI security collaborations, edge AI projects, and quantum-classical systems. There is more to AMD than the fresh US$1 trillion market cap...
Advanced Micro Devices (AMD) Is Up 24.7% After Expanding Its Role In Regulated AI Infrastructure – Has The Bull Case Changed?
Advanced Micro Devices has recently been at the center of a series of AI-focused developments, from powering MindWalk’s OpenFold3 life-sciences workloads on Instinct MI325X GPUs to expanding ecosystem collaborations across edge AI, quantum-classical integration, and agentic AI security and infrastructure. Together, these partnerships and deployments highlight AMD’s role not just as a chip supplier but as a foundational compute layer for regulated, production-grade AI systems spanning data...
MindWalk Brings OpenFold3 into Production in Minutes with AMD Inference Microservices on Vultr Kubernetes Engine
AUSTIN, Texas, September 21, 2026--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today announced results from a production deployment of the open-source OpenFold3 structure prediction model, run with engineering partners AMD and Vultr on Vultr Kubernetes Engine and Vultr Cloud GPU powered by AMD Instinct™ MI325X GPUs and delivered through AMD Inference Microservices (AIM). It also served as an independent validation of AIM for OpenFold3 in a production life-scienc
MindWalk Holdings Corp (HYFT) (Q1 2027) Earnings Call Highlights: Revenue Climbs 21% as ReefIQ ...
MindWalk Holdings Corp (HYFT) posts a fifth straight quarter of revenue growth with gross margin expanding to 59%, while investing heavily in the commercial rollout of its ReefIQ data platform.
MindWalk (HYFT) Q1 2027 Earnings Call Transcript
ReefIQ launch drives 21% revenue growth amid strategic shift to recurring platform partnerships.
MindWalk Holdings Corp. Q1 2027 Earnings Call Summary
Moby summary of MindWalk Holdings Corp.'s Q1 2027 earnings call
MindWalk Holdings (NASDAQ:HYFT) Falls After Q1 Revenue Miss and Wider Loss
Mindwalk Holdings (HYFT) Q1 revenue misses estimates; shares fall after hours despite gross margin rising to 58.6% and 21% revenue growth.
MindWalk Holdings Corp. (HYFT) Reports Q1 Loss, Misses Revenue Estimates
MindWalk Holdings Corp. (HYFT) delivered earnings and revenue surprises of -80.00% and -15.48%, respectively, for the quarter ended July 2026. Do the numbers hold clues to what lies ahead for the stock?
MindWalk Q1 Earnings Call Highlights
MindWalk (NASDAQ:HYFT) reported first-quarter fiscal 2027 revenue of CAD 3.8 million, up 21% from CAD 3.2 million a year earlier, as the company continued investing in commercialization of its ReefIQ biological-data platform and expanded its drug discovery partnership model. Gross margin increased
MindWalk Reports 21% Revenue Growth and Gross Margin Expansion to 59% in Fiscal First Quarter 2027
AUSTIN, Texas, September 14, 2026--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today reported financial results for its fiscal 2027 first quarter ended July 31, 2026. The quarter marked the commercial launch of ReefIQ™, MindWalk's data platform, and the start of its shift toward recurring, platform-based revenue.
MindWalk Holdings Corp. (HYFT) Q1 2027 Earnings Call Transcript
MindWalk Holdings Corp. (HYFT) Q1 2027 Earnings Call September 14, 2026 5:00 PM EDTCompany ParticipantsJennifer Bath - CEO, President & Non-Independent...
Transcript: MindWalk Holdings Q1 2027 Earnings Conference Call
On Monday, MindWalk Holdings (NASDAQ:HYFT) discussed first-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga APIs. For real-time
MindWalk Holdings Q1 EPS $(0.09) Misses $(0.05) Estimate, Sales $2.770M Miss $3.250M Estimate
MindWalk Holdings (NASDAQ:HYFT) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.05) by 80 percent. This is a 28.57 percent decrease over losses of $(0.07) per share from
MindWalk Lands Binding Commitment for US$30 Million Unsecured Credit Facility to Fund Biologics Programs and Commercial Expansion
AUSTIN, Texas, September 14, 2026--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today announced that it has entered into a binding commitment with Sanabil (Cayman) for a senior unsecured revolving credit facility of up to US$30 million. The facility is intended to support MindWalk’s biologics programs, commercial expansion, working capital, and general corporate purposes.
MindWalk Enters Binding Commitment With Sanabil For Senior Unsecured Revolving Credit Facility Of Up To $30M
The facility is intended to support MindWalk’s biologics programs, commercial expansion, working capital, and general corporate purposes. The facility carries a fixed annual interest rate of 7.00%, accruing only on
MindWalk to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
AUSTIN, Texas, September 10, 2026--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today announced that it is participating in the H.C. Wainwright 28th Annual Global Investment Conference, held September 14 - 16, 2026 at the Lotte New York Palace Hotel in New York, where a pre-recorded fireside chat with Chief Executive Officer Dr. Jennifer Bath is available to registered attendees on demand.
MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2027 on September 14, 2026
AUSTIN, Texas, September 08, 2026--MindWalk Holdings Corp. ("MindWalk" or the "Company") (NASDAQ: HYFT), a Bio-Native AI company, today announced that it will report financial results for the first quarter of fiscal year 2027 and host a conference call on Monday, September 14, 2026, at 5:00 p.m. Eastern Time. Financial results will be issued in a press release prior to the call, which will include a management presentation followed by a question-and-answer session.
AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030
Equity Insider News Commentary - Pharmaceutical research is being rebuilt around artificial intelligence faster than the industry can absorb it. Arizton values the global AI in drug discovery market at approximately $1.71 billion in 2024 and projects it will reach roughly $8.52 billion by 2030, a compound annual growth rate of about 30.58%. That is a market compounding at more than double the rate of most enterprise software categories, and it is being spent inside an industry that already inves